HIV Medicine in Clinical Practice Maintenance of Certification

 

The IDSA HIV Medicine in Clinical Practice MOC Module  is a tool for self-evaluation of medical knowledge in HIV Medicine in Clinical Practice medicine. The module consists of 30 multiple-choice questions; the majority contain case-based information and all include educational links and answer rationales. IDSA is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. IDSA designates this enduring material (module) for a maximum of 11 AMA PRA Category 1 Credits.™

Target Audience

This CME activity is intended for infectious diseases physicians, ID academicians, and internal medicine physicians.

Learning Objectives

At the conclusion of this activity, the learner will be able to:

  • Identify gaps in HIV medical knowledge where further study is needed for board preparation and patient care
  • Improve competence in the area of HIV medicine regarding diagnosis, treatments, and other aspects of patient management
  • Evaluate and revise patient management strategies
  • Improve clinical decision-making skills in HIV medicine

Additional Information

AttachmentSize
IDSA_PrivacyAndUse.doc61.55 KB
NLVs.doc245.48 KB
Course summary
Available credit: 
  • 11.00 ABIM MOC II
  • 11.00 AMA PRA Category 1 Credit(s)™
Course opens: 
01/01/2019
Course expires: 
12/31/2019
Cost:
$100.00
Rating: 
0
Faculty and Disclosures

Michael A Horberg, MD, MAS, FACP, FIDSA, Executive Director Research and Community Benefit, MAPMG, PC; Senior Physician, Mid-Atlantic Permanente Medical Group, Inc.; Principal Investigator, NIMH: Optimizing Multidisciplinary Care Teams for Maximal HAART Adherence; Co-principal investigator, Pfizer: Surveillance of Ongoing Clinical Events in HIV-Infected Patients; Principal investigator, Merck Laboratories: Observational Post-Authorization Study of Patients Treated with Raltegravir; Co-principal investigator, AHRQ: Preventive Health Index for HIV-Infected Population

 

Judith A. Aberg, M.D., FIDSA, FACP, Director of Virology, Bellevue Hospital Center; Director of the Division of Infectious Disease & Immunology; Professor of Medicine New York University School of Medicine. Advisory/Consultant Role: GSK-Pfizer (Viiv), Merck, Tibotec

 

Bradley L Allen, MD, FACP, FIDSA, Roudebush VAMC Indianapolis, Staff, Internal Medicine and Infectious Diseases; Indiana University, Associate Professor of Clinical Medicine and Infectious Diseases; Vice Chair for Education, Department of Medicine; Reed Hospital, Richmond, Indiana: Honoraria; Research Grants Contracts: Romark, Mid-Atlantic VAMC Consortium, Merck

 

Jean R Anderson, MD, Professor, Department of Gynecology and Obstetrics; Director, Division of Gynecologic Specialties, Johns Hopkins University; Honoraria, Clinical Care Options; AAHIVM (writing learning modules); Honoraria, Office of Population Affairs/Office of Family Planning

 

Barbara Gripshover, MD, Medical Director, John T. Carey Special Immunology Unit; Infectious Diseases clinician, University Hospitals of Cleveland Medical Group; Associate Professor of Medicine, Department of Medicine, Division of Infectious Disease and HIV Medicine, Case Western Reserve; nothing to disclose

 

Roy M Gulick MD, Professor of Medicine; Chief of Division of Infectious Diseases, Weill Cornell Medical College; Advisory/Consultant Role: Bristol-Myers Squibb; Gilead; Janssen, Koronis

 

Jonathan E Kaplan, MD, FIDSA, Chief, HIV Care and Treatment Branch, Global AIDS Program, Center for Global Health, Centers for Disease Control and Prevention; nothing to disclose

 

J Martin Rodriguez, MD, Associate Professor of Medicine, University of Alabama at Birmingham; nothing to disclose

 

Michael S Saag, MD, Professor of Medicine, University of Alabama at Birmingham; Staff physician, UAB Health Services; Advisory/Consultant Role: Ardea, Avexa; BIPI, BMS, Gilead, GSK, Merck, Pfizer, Tibotec, Jannsen, Monogram, ViiV, Vertex

 

Staff:

Kathleen Matikonis, MA, IDSA Senior Education Officer; nothing to disclose

Rachel Shnekendorf, MPH, IDSA Senior Education Officer; nothing to disclose

Independent Reviewer:

Harry Gallis, MD, Consulting Professor of Medicine, Duke University Medical Center; Advisor/Consultant: Meniscus Education, Fortis-Spectrum; CME Consultant to American College of Cardiology, North Carolina Medical Society.

 

© Copyright 2013 IDSA. All rights reserved. Questions in this module may not be copied, distributed or adapted.

Accreditation Statement
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
IDSA designates this enduring material for a maximum of 11 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician participation information will be shared with ABIM through ACCME PARS.

 

Available Credit

  • 11.00 ABIM MOC II
  • 11.00 AMA PRA Category 1 Credit(s)™

Accreditation Period

Course opens: 
01/01/2019
Course expires: 
12/31/2019

Price

Cost:
$100.00
Please login or register to take this course.

Required Hardware/software

PCs Running Window

  • Windows 10  
  • Microsoft Edge
  • Firefox
  • Google Chrome

Apple Computers Running OSX

  • Safari
  • Firefox
  • Google Chrome